Clinical Trials Directory

Trials / Terminated

TerminatedNCT03998189

Metabolic and Microbial Profiling of Lung Cancer

Pilot Study: Metabolic and Microbial Profiling of Lung Cancer

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
1 (actual)
Sponsor
Wake Forest University Health Sciences · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This pilot study will establish non-invasive sample collections, including breath, saliva, blood and urine pre-surgery and at the participant's one-month post-surgery follow-up visit. Participants with suspected non-small cell lung cancer (NSCLC) stage I-III will be recruited.

Detailed description

Primary Objective * To evaluate the feasibility of adding non-invasive sample collections in the pre-surgical setting and at the post-surgery follow-up visit. * To identify and assess metabolic and microbial signatures collected at pre- and post-surgery and determine which are indicative of lung cancer. Secondary Objective * To identify signatures which are associated with lung cancer stage. * To identify signatures which are impacted by patient's pulmonary function status.

Conditions

Interventions

TypeNameDescription
OTHERBreath CollectionPre-surgery, two 500 ml of exhaled breath volatiles (EBV) in each of 4 collection tubes will be collected in 5-7 min of breathing
OTHERSaliva CollectionPre-surgery, 2 ml minimum of saliva will be collected into SalivaBio Passive Drool collection tubes
OTHERBlood CollectionPre-surgery, an optional 5 ml blood sample in each redtop and purple top vacutainer blood collection tube
OTHERUrine CollectionPre-surgery, 25 ml minimum of urine will be collected in sterile specimen containers
OTHERTumor CollectionDuring surgical tumor removal, a tumor tissue sample will be collected
OTHERMedical History Data CollectionMedical history will be obtained from the patients charts to identify demographics (age, race, ethnicity, zip code), oncologic history (date of diagnosis and cancer type), and medical history of disease.

Timeline

Start date
2019-10-11
Primary completion
2021-06-21
Completion
2021-06-21
First posted
2019-06-26
Last updated
2021-11-05
Results posted
2021-11-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03998189. Inclusion in this directory is not an endorsement.